Cardiol Therapeutics
CRDL
33 hedge funds and large institutions have $10.7M invested in Cardiol Therapeutics in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 1 closing their positions.
1,400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 1
594% more call options, than puts
Call options by funds: $2.05M | Put options by funds: $296K
74% more funds holding
Funds holding: 19 → 33 (+14)
62% more capital invested
Capital invested by funds: $6.62M → $10.7M (+$4.1M)
5.78% more ownership
Funds ownership: 3.74% → 9.52% (+5.8%)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$8.71M |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
+$1.26M |
| 3 |
Two Sigma Investments
New York
|
+$537K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$489K |
| 5 |
Goldman Sachs
New York
|
+$296K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$168K |
| 2 |
Renaissance Technologies
New York
|
-$143K |
| 3 |
Jane Street
New York
|
-$73.6K |
| 4 |
Morgan Stanley
New York
|
-$49.8K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$34.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
26
Commons Capital
Needham,
Massachusetts
| $5K | +$6.91K | +2,500 | New |
|
|
27
Bank of America
Charlotte,
North Carolina
| $2K | -$34.5K | -12,508 | -91% |
|
|
CSB
28
City State Bank
Norwalk,
Iowa
| $2K | +$2.28K | +825 | New |
|
|
TCM
29
Tradewinds Capital Management
Bellingham,
Washington
| $1K | – | – | – |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| – | -$5.25K | -1,900 | -88% |
|
|
PSB
31
Piscataqua Savings Bank
Portsmouth,
New Hampshire
| – | -$4K | -1,000 | Closed |
|
32
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$1.71K | -620 | -70% |
|
|
CG
33
Cutler Group
San Francisco,
California
| – | +$17 | +6 | New |
|
|
KCM
34
KRS Capital Management
Bloomfield,
Michigan
| – | +$276 | +100 | New |
|
CRDL Hedge Fund Activity: Q4 2021 in Review
33 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cardiol Therapeutics (CRDL) for Q4 2021, worth a combined $10.7M — up 62% from $6.62M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new CRDL positions and 1 closed out — a net gain of 14 holders — while 7 added to existing stakes and 8 trimmed.
The largest buyer was MMCAP International, opening a new position worth an estimated $8.71M. The largest seller was Virtu Financial, cutting an estimated $168K.
- 33 institutional investors held Cardiol Therapeutics (CRDL) as of Q4 2021, up from 19 in Q3 2021.
- Funds reported $10.7M of Cardiol Therapeutics stock for Q4 2021, up 62% quarter-over-quarter.
- 15 funds opened new Cardiol Therapeutics positions in Q4 2021 and 1 closed out, a net change of +14 holders.
- The largest Cardiol Therapeutics buyer in Q4 2021 was MMCAP International, an estimated $8.71M added.
- The largest Cardiol Therapeutics seller in Q4 2021 was Virtu Financial, an estimated $168K sold.
Based on aggregated 13F filings for Q4 2021.